Neurotech International Ltd. (AU:NTI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neurotech International Ltd (ASX: NTI) has announced the expiry of its listed options (ASX: NTIOA) on January 30, 2025, with a $0.135 exercise price. Investors have the option to exercise, sell, or let their options lapse before the final trading day on January 23, 2025. This development provides a crucial decision point for stakeholders interested in the company’s innovative biopharmaceutical ventures, particularly in the pediatric neurological disorder space.
For further insights into AU:NTI stock, check out TipRanks’ Stock Analysis page.